It’s been almost a decade since Japanese pharma company Daiichi Sankyo began its dramatic pivot from cardiovascular health into antibody-drug conjugates. For Daiichi Sankyo, it’s hard to argue that ...
Kelly-Ann Franklin has spent more than two decades in journalism which has helped her build a wide knowledge base of business and personal finance topics. Her goal with editing is to ensure tough ...
Daiichi Sankyo and AstraZeneca announce on Friday that their co-developed innovative medicine, Enhertu, has been approved for use in China as a neoadjuvant treatment for early-stage breast cancer.
If you’re in search of a card that gives you the convenience of paying with plastic without the risk of overspending, consider a prepaid debit card. We analyzed 34 prepaid debit cards from 28 ...
The biggest stories of the day delivered to your inbox.
Some offers mentioned below are no longer available. When you're in the market for a new credit card, it's worth considering the short- and long-term impact that adding a new one could have on your ...
SAN DIEGO--(BUSINESS WIRE)--Voro Therapeutics, a biotechnology company pioneering tumor-activated biologics using its proprietary PrimeBody platform, today announced a research collaboration with ...
Personal and small business cards issued by Discover are currently not available on CNBC Select and links have been redirected to our credit card marketplace where you can review offers from other ...
Fortunately, just like with video game storage, there are all sorts of carefully crafted containers you can use to protect your trading cards these days. If you’re just getting into collecting now, ...
We may receive a commission on purchases made from links. E-readers have gone through many evolutions over the years, and adding color displays might be the best idea yet. Granted, there's nothing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results